Headlands Technologies
AZR icon

Headlands Technologies’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Headlands Technologies’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$85 – 1111
2024
Q1 		$85 Buy
+3
New +$112 ﹤0.01% 1215

Other funds holding AZR

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
1620 Investment Advisors
1620 Investment Advisors Plymouth, Massachusetts $160M AUM 20.87% 1-Year Est. Return
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return

Headlands Technologies's AZR Position: Q2 2024 in Review

Headlands Technologies sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q2 2024, closing a stake of 3 shares — an estimated $85 sold.

Headlands Technologies first reported a position in AZR in Q1 2024 and held it in 1 quarter. The position peaked at $85 in Q1 2024. 15 funds tracked by Wall St. Rank hold AZR as of Q2 2024.

  • Headlands Technologies reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Headlands Technologies sold 3 Azora Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $85.
  • Headlands Technologies first reported a position in Azora Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Headlands Technologies's Azora Therapeutics, Inc. Common Stock position peaked at $85 in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Headlands Technologies's 13F filing for Q2 2024, filed 7 Aug 2024.